On Tuesday, the Food and Drug Administration (FDA or the agency) published a draft guidance document, "Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements," which offers recommendations on how companies can best present quantitative efficacy and risk information in direct-to-consumer (DTC) promotional materials.
Please see full publication below for more information.